Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping
暂无分享,去创建一个
Ruben Abagyan | Laurence J Miller | Patrick M Sexton | Andrew Orry | Maoqing Dong | Xiequn Xu | R. Abagyan | P. Sexton | P. Lam | A. Orry | L. Miller | M. Dong | Xiequn Xu | D. Pinon | Alicja M Ball | Joshua A Makhoul | Polo C-H Lam | Delia I Pinon | Alicja M. Ball | Joshua A. Makhoul
[1] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[2] H. Jüppner,et al. Identification of Determinants of Inverse Agonism in a Constitutively Active Parathyroid Hormone/Parathyroid Hormone-related Peptide Receptor by Photoaffinity Cross-linking and Mutational Analysis* , 2001, The Journal of Biological Chemistry.
[3] D. Drucker,et al. International Union of Pharmacology. XXXV. The Glucagon Receptor Family , 2003, Pharmacological Reviews.
[4] C. Sander,et al. Errors in protein structures , 1996, Nature.
[5] A. Couvineau,et al. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] P. Robberecht,et al. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC2: role of basic residues in the second transmembrane helix , 2001, British journal of pharmacology.
[7] L. Miller,et al. Importance of each residue within secretin for receptor binding and biological activity. , 2011, Biochemistry.
[8] Elizabeth Buck,et al. Site-specific Disulfide Capture of Agonist and Antagonist Peptides on the C5a Receptor* , 2005, Journal of Biological Chemistry.
[9] L. Miller,et al. Differential determinants for coupling of distinct G proteins with the class B secretin receptor. , 2012, American journal of physiology. Cell physiology.
[10] Albert C. Pan,et al. Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.
[11] P. Robberecht,et al. Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction* , 2001, The Journal of Biological Chemistry.
[12] Laurence J Miller,et al. Spatial Approximations between Residues 6 and 12 in the Amino-terminal Region of Glucagon-like Peptide 1 and Its Receptor , 2010, The Journal of Biological Chemistry.
[13] B. Wulff,et al. Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus* , 2003, Journal of Biological Chemistry.
[14] R. Heinzen,et al. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii , 2007, Cellular microbiology.
[15] M. Fan,et al. Transmembrane Residues of the Parathyroid Hormone (PTH)/PTH-related Peptide Receptor That Specifically Affect Binding and Signaling by Agonist Ligands* , 1996, The Journal of Biological Chemistry.
[16] B Sollner-Webb,et al. High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. , 1984, Nucleic acids research.
[17] R. Rudolph,et al. Passing the baton in class B GPCRs: peptide hormone activation via helix induction? , 2009, Trends in biochemical sciences.
[18] R. Abagyan,et al. Spatial Approximation between Secretin Residue Five and the Third Extracellular Loop of Its Receptor Provides New Insight into the Molecular Basis of Natural Agonist Binding , 2008, Molecular Pharmacology.
[19] Elizabeth Buck,et al. Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Gardner,et al. Interaction of synthetic 10-tyrosyl analogues of secretin with hormone receptors on pancreatic acinar cells. , 1977, Gastroenterology.
[21] P. de Neef,et al. Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor. , 1999, Receptors & channels.
[22] Jean-Luc Pellequer,et al. Multi‐template approach to modeling engineered disulfide bonds , 2006, Proteins.
[23] Angela Wittelsberger,et al. Mapping peptide hormone-receptor interactions using a disulfide-trapping approach. , 2008, Biochemistry.
[24] G. Bitan,et al. Photoaffinity Cross-linking Identifies Differences in the Interactions of an Agonist and an Antagonist with the Parathyroid Hormone/Parathyroid Hormone-related Protein Receptor* , 2000, The Journal of Biological Chemistry.
[25] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[26] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[27] P. de Neef,et al. Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin , 1998, FEBS letters.
[28] Ruben Abagyan,et al. Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor , 2009, Molecular Pharmacology.
[29] L. Miller,et al. Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. , 2009, International journal of peptide and protein research.
[30] T. Lybrand,et al. Spatial Approximation between the Amino Terminus of a Peptide Agonist and the Top of the Sixth Transmembrane Segment of the Secretin Receptor* , 2004, Journal of Biological Chemistry.
[31] D. Drucker,et al. The Glucagon Receptor Family , 2000 .
[32] R. Rudolph,et al. Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor , 2007, Proceedings of the National Academy of Sciences.
[33] Ruben Abagyan,et al. Molecular Basis of Secretin Docking to Its Intact Receptor Using Multiple Photolabile Probes Distributed throughout the Pharmacophore* , 2011, The Journal of Biological Chemistry.
[34] Brian K Shoichet,et al. Structure-based drug screening for G-protein-coupled receptors. , 2012, Trends in pharmacological sciences.
[35] A. Couvineau,et al. Class-B GPCR activation: is ligand helix-capping the key? , 2008, Trends in biochemical sciences.
[36] M. Beyermann,et al. Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues. , 2005, Biochemistry.
[37] L. Miller,et al. Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.
[38] L. Miller,et al. Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor* , 2007, Journal of Biological Chemistry.
[39] Arthur Christopoulos,et al. Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands* , 2007, Journal of Biological Chemistry.
[40] C. Ulrich,et al. Molecular cloning and functional expression of a human pancreatic secretin receptor. , 1995, Biochemical and biophysical research communications.
[41] Ian S. Hagemann,et al. Structure of the Complement Factor 5a Receptor-Ligand Complex Studied by Disulfide Trapping and Molecular Modeling* , 2008, Journal of Biological Chemistry.
[42] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[43] S. Datta,et al. Packing-induced Conformational and Functional Changes in the Subunits of α-Crystallin* , 2000, The Journal of Biological Chemistry.
[44] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.